David Erickson | Vice President, Investor Relations |
David Moatazedi | President and Chief Executive Officer |
Rui Avelar | Chief Medical Officer and Head of Research and Development |
Louise Chen | Cantor Fitzgerald |
Annabel Samimy | Stifel |
Marc Goodman | SVB |
Greg Fraser | Truist Securities |
Serge Belanger | Needham and Company |
Douglas Tsao | H.C. Wainwright |
Uy Ear | Mizuho |
Greetings. Welcome to the Evolus Second Quarter 2022 Earnings Call. At this time, our participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded.